Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Mar 13, 2024 11:13am
RE:Why no Allergan product?
Botox has 13 indications and a variety and of competitors, although flattering that they may see minuscule Sirona as a threat, Howie over-emphasized statements likely didn't help this partner
...more
(2113)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Mar 13, 2024 11:08am
RE:They have a real product to compete with BOTOX!
So why aren't you buying? Put your money where your big mouth is.
(2175)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Mar 13, 2024 11:07am
RE:They have a real product to compete with BOTOX!
1326 is both a skin sculpter (botox and derm fillers) and skin rejuvenator (retinols)
(101)
•••
biorun
X
View Profile
View Bullboard History
Post by
biorun
on Mar 13, 2024 10:39am
They have a real product to compete with BOTOX!
Not sure the market is appreciating what was just announced. The fact that have a serum formulated and now will be sent to "stakeholders" should tell us something here. I take "
...more
(2113)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Mar 13, 2024 10:30am
RE:RE:New Press Release - Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations
AbbVie was supposed to be providing the cash flow for general operational expenses. Too bad that appears to be another R&F fiasco.
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Mar 13, 2024 9:35am
RE:New Press Release - Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations
The last minute transparency is crucial to maintain the trust that is left at this stage. I like the strategy to distribute samples to stakeholders - why not send it my way as well! Let's get rid
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 13, 2024 9:00am
New Press Release - Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations
VANCOUVER, British Columbia, March 13, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or the “Company”) announces a significant achievement in its quest to transform the skincare industry. Its subsidiary, TFChem, has successfully received formulations...
read article.
(2113)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Mar 13, 2024 8:57am
RE:RE:Why no Allergan product?
You should read Turtle's post again. Your reponse is nonsense.
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Mar 13, 2024 8:35am
RE:Why no Allergan product?
The Abbvie/Allergan deal concerns TFC-1067 and I deem the compound to be stand-alone. Can't see any reason why the Glycoprotemim statement should have impact. I am positive to TFC-1326 as Sirona
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Mar 13, 2024 7:49am
RE:Why no Allergan product?
1326 doesn't go away unless a theoretical recievor under a distressed asset sale hides it away 20,000 leagues under the sea like the Caramel secret. Even then Geraldine would find a way to use a
...more
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Post by
Turtle4
on Mar 13, 2024 6:00am
Why no Allergan product?
I think Allergan was really working at high pressure on a launch. But then Sirona published the following sentence about the Gycoprotemim study: "TFC-1326 could be a stand-alone product for
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Mar 12, 2024 7:13pm
RE:RE:RE:RE:RE:RE:RE:RE:Profile
Big Pharma could not care less whether Sirona had 500k or 500M in their account. They March to their own tune. What I take issue with is there sequential approach to everything. Every deal they get
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Mar 12, 2024 5:55pm
RE:RE:RE:RE:RE:RE:RE:Profile
Howie has proven he does not have any negotiation skills and foresight. Assuming there is some sort of penalty, it will just go to paying off Howies loan to himself. So I guess he has himself
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Mar 12, 2024 4:52pm
RE:RE:RE:RE:RE:Profile
I understand that they continue to have regular meetings with AbbVie so that doesn't sound dead to me. And they continue to indicate on their presentation updates they are exploring other products
...more
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario